EGFR has been the most extensively studied with ... Activation of the ERBB receptors involves many components of the receptors, from the ligand binding in the extracellular domain to the kinase ...

No writing assistance was utilized in the production of this manuscript. Ligand-mediated EGF receptor (EGFR) targeting of nanovehicles is an effective way for cancer cell-selective delivery of ...

testing for the programmed death receptor-ligand 1 (PD-L1) expression. EGFR-activating mutations are the most common driver mutations in NSCLC. Targeted therapies included first-generation ...